Mankind Pharma Limited (NSE:MANKIND)
2,163.30
-23.70 (-1.08%)
Mar 9, 2026, 3:30 PM IST
-5.46% (1Y)
| Market Cap | 902.80B -12.5% |
| Revenue (ttm) | 139.14B +19.5% |
| Net Income | 17.79B -12.8% |
| EPS | 43.10 -15.2% |
| Shares Out | 412.81M |
| PE Ratio | 50.62 |
| Forward PE | 38.75 |
| Dividend | 2.00 (0.09%) |
| Ex-Dividend Date | n/a |
| Volume | 825,818 |
| Average Volume | 490,739 |
| Open | 2,131.00 |
| Previous Close | 2,187.00 |
| Day's Range | 2,108.30 - 2,170.80 |
| 52-Week Range | 2,012.30 - 2,716.50 |
| Beta | 0.18 |
| RSI | 54.90 |
| Earnings Date | May 22, 2026 |